DCAL — Dishman Carbogen Amcis Share News
0.000.00%
Last trade - 00:00- IN₹21.37bn
- IN₹41.82bn
- IN₹29.32bn
Brief: Dishman Carbogen Amcis Says Us FDA Completes Inspection At Co's Facility In Ahmedabad
Brief: Dishman Carbogen Amcis Says Bavla Site Has Been Declared Gmp Compliant By Japanese Pharmaceuticals And Medical Devices Agency
Brief: Dishman Carbogen Amcis Says Bavla Site Successfully Inspected By EDQM, Italian Medicines Agency
Brief: India's Dishman Carbogen Amcis June-Quarter Consol Net PAT Rises
Brief: Dishman Carbogen Amcis’S Bavla Site Inspected By Japanese Pharmaceuticals And Medical Devices Agency (PMDA), Final Report Awaited
India's Dishman Carbogen tumbles 12% after quarterly loss widens
Brief: India's Dishman Carbogen Amcis March-Quarter Consol Net Loss After Tax Widens
India's Dishman Carbogen climbs after investor Mukul Agrawal raises stake
India New Issue-Dishman Carbogen Amics to issue over 3-year bonds - traders
India's Dishman Carbogen Amcis falls most in 7 months
Brief: Dishman Carbogen Amcis Approved Issuance Of Non-Convertible Debentures Up To 1 Billion Rupees
Brief: Dishman Carbogen Amcis To Consider Fund Raising By Issuance Of Non-Convertible Debentures
Brief: Dishman Carbogen Amcis Says Carbogen Amcis AG's Manufacturing Site In Switzerland Has Completed A Routine USFDA Inspection
Dec-Quarter Consol Net Pat Rises
Brief: Dishman Carbogen Amcis Opened A Facility in France
Brief: Dishman Carbogen Amcis Approved Issuance Of Non-Convertible Debentures Aggregating Up To 1 Billion Rupees
Brief: Dishman Carbogen Amcis To Consider Fund Raising By Way Of Issuance Of Non- Convertible Debentures By Private Placement Basis
Brief: Dishman Carbogen Amcis Has Informed EDQM Regarding Readiness For Re-Inspection Of Bavla Site
India's Dishman Carbogen rises on unit clearing Swissmedic inspection